Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Dumping 20M shares and keeping 10M warrants @$3.18

<< Previous

Bullboard Posts

Next >>

Comment by palinc2000on Jan 28, 2021 6:46am

157 Views

Post# 32407109

RE:RE:Dumping 20M shares and keeping 10M warrants @$3.18

Comments:
1-The number of shares issued is 16 million not 19 million

2-Apparently there are about 10 million Units in the hands of 3 presumed to be long term holders
3- That would leave about 6 million shares in the hands of retail /short term holders of which approximaty 2.5-3.0 have sold already and kept the Warrants as you explained
4- Thus there are still some 3 million shares held by the original acquirer and I also think most of them will get rid of the shares in any subsequent spikes in the SP

5-Yes it is an atrocious deal for legacy shareholders

<< Previous

Bullboard Posts

Next >>

Level up your trading with BMO InvestorLine’s enhanced features